Bristol-Myers Squibb Co banner
Financial profile · Q2 FY2026

A cash-generating pharmaceutical portfolio managing product-cycle pressure

Bristol Myers Squibb combines modest long-run revenue growth with recurring operating and free cash generation and relatively modest capital requirements. Reported earnings are more volatile than cash flow because acquisitions, amortization, impairments, pricing changes, and patent-driven generic erosion affect the income statement.

What is developing

The June 30, 2026 results show a meaningful development rather than a new financial model: growth-portfolio demand is offsetting legacy-product erosion, while quarterly operating margin and cash generation improved. The underlying profile remains a cash-generative pharmaceutical business with moderate capital intensity.

What matters next

Whether growth-portfolio revenue and operating cash flow continue to offset legacy-product erosion and Eliquis-related cash-collection pressure.

USD
Metric FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
19.4B 20.8B 22.6B 26.1B 42.5B 46.4B 46.2B 45B 48.3B 48.2B
(4.9B) (5.8B) (6.4B) (7.8B) (11.1B) (9.6B) (10.1B) (10.6B) (11.9B) (13.2B)
14.5B 15B 16.1B 18.3B 31.4B 36.8B 36.1B 34.4B 36.4B 35B
(8.7B) (8.2B) (8.4B) (11.1B) (23.7B) (25B) (24.7B) (23.5B) (24.8B) (18.1B)
(4.9B) (4.7B) (4.6B) (4.9B) (7.7B) (7.7B) (7.8B) (7.7B) (8B) (7.1B)
R&D
(4.5B) (4.8B) (5.1B) (5.8B) (9.5B) (9.5B) (9.4B) (9.2B) (9.8B) (9.5B)
(21m) (3m) (41m) (1.2B) (9.7B) (10B) (9.6B) (9B) (8.9B) (3.3B)
719m 1.4B 1.4B 837m 3.3B 2.3B 2.1B 2.4B 1.8B 1.9B
5.8B 6.8B 7.8B 7.3B 7.7B 11.8B 11.4B 10.9B 11.5B 16.9B
15m 33m (380m) (69m) (71m) (550m) (1.9B) (877m) (1.5B) (1B)
167m 196m 183m 656m 1.4B 1.3B 1.2B 1.2B 1.9B 1.9B
55m (1.8B) (1.3B) (2.5B) (14.6B) (3.2B) (1.7B) (1.4B) (18.4B) (6.5B)
44m 16m (65m) 256m 34m 18m (90m) (106m) (46m) (11m)
5.9B 5.1B 6B 5B (6.9B) 8.1B 7.7B 8.4B (8.4B) 9.3B
(1.4B) (1.3B) (965m) (1.5B) (2.1B) (1.1B) (1.4B) (400m) (554m) (2.3B)
4.5B 3.9B 5B 3.5B (9B) 7B 6.3B 8B (8.9B) 7.1B
(50m) 32m (27m) (21m) (20m) (20m) (18m) (15m) (15m) (2m)
4.5B 1B 4.9B 3.4B (9B) 7B 6.3B 8B (8.9B) 7.1B
2.65 0.60 3.00 2.01 (3.99) 3.12 2.95 3.86 (4.41) 3.46